• Study on Infection Prevention in Joint Replacement Surgery Using Povidone, Chlorhexidine, and Vancomycin for Adult Patients

    Recruiting

    3 1 1 1
    Spain
  • Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated drugs:
    France Germany Greece Italy Portugal Spain
  • Study on Early Detection and Treatment of ER Positive HER2 Negative Breast Cancer Using Palbociclib, Fulvestrant, and Drug Combination for Patients with Molecular Relapse

    Recruiting

    2 1 1 1
    France
  • Study on Sirolimus and Mycophenolate Mofetil for Reducing Hernia Risk in Type 1 Diabetes Patients with End-Stage Kidney Disease Undergoing Pancreas and Kidney Transplantation

    Recruiting

    3 1 1 1
    Czechia
  • Study on Tocilizumab for Treating Acute Chest Syndrome in Children and Adults with Sickle Cell Disease

    Recruiting

    3 1 1
    Investigated diseases:
    France
  • Safe Discontinuation of Antidepressants in Patients with Remitted Depression: Amitriptyline, Fluoxetine, Paroxetine, and Drug Combination Study

    Recruiting

    3 1 1 1
    Investigated diseases:
    Italy
  • Study of 89Zirconium-labeled ipilimumab distribution in patients with metastatic melanoma receiving ipilimumab/nivolumab combination therapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated drugs:
    Italy
  • Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

    Recruiting

    4 1 1 1
    Austria Belgium Czechia Denmark France Germany +6
  • Comparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit

    Recruiting

    3 1 1 1
    Investigated diseases:
    Italy

powered by